YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ken W who wrote (409)	9/9/2002 1:43:24 PM
From: Sergio H	Read Replies (1) of 23958

Ken, CLGY presents a lot of risk, even at $2 a pop. Today's news cites that the new study for Cellegesic will cost about $1 million bucks. CLGY is about to run out of money, so the new study is probably not forthcoming. They also have to pay back the funds generated from the Cellegesic marketing agreement. Their only potential source of money right now is a marketing agreement for Tostrex, which is due for an FDA decision in early 2003. One analyst put out a short term avoid rating on CLGY this morning due to all of the uncertainty surrounding the company. Sergio

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next